Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
13.7M
-
Shares change
-
-153K
-
Total reported value, excl. options
-
$114M
-
Value change
-
-$1.01M
-
Number of buys
-
15
-
Number of sells
-
-9
-
Price
-
$8.32
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q1 2015
32 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q1 2015.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.7M shares
.
Largest 10 shareholders include NEA Management Company, LLC (8.58M shares), WELLINGTON MANAGEMENT GROUP LLP (2.62M shares), FRANKLIN RESOURCES INC (892K shares), Cormorant Asset Management, LLC (459K shares), Candriam Luxembourg S.C.A. (235K shares), VANGUARD GROUP INC (208K shares), WALL STREET ASSOCIATES (150K shares), Spark Investment Management LLC (76.6K shares), JPMORGAN CHASE & CO (75.5K shares), and GOLDMAN SACHS GROUP INC (74K shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.